Ovarian cancer patients given fresh hope thanks to double drug treatment

Ruth Joy (pictured), from West Sussex, was diagnosed with advanced, slow-growing ovarian cancer in 2006. She has benefitted from a clinical trial involving MEK inhibitors and defactinib.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news